XOMA Corporation Spikes on Price Offering

Jacob Harper |

Biotech company XOMA Corporation ($XOMA) announced the price of their common stock offering on Thursday that sent the price of shares on an upward trajectory.

XOMA is offering 7.6 million shares at $3.62 a share, which should net the company around $25.5 million. Also, the company is allowing underwriters a 30 day option on an additional 1.14 million shares.

The Berkeley, Ca.-based biotech firm's flagship drug (and focus of principal reserach) is called gevokizumab. The drug is a humanized monoclonal antibody which is used primarily in the treatment of diabetes. On July 22 the drug entered Phase 2 of the approval process. Gevokizumab is also currently in phase III development for treating non-infectious uveitis and Behçet’s uveitis, which are multiskeletal inflammatory disorders.

On Aug. 7, the company reported a 21 cent per-share loss for the second quarter of 2013, missing revenue estimates by 21 percent. XOMA’s stock dropped precipitously on the news, losing around 20 percent of its value. In March, the stock was thought to be the most undervalued biomed stock under $10.

XOMA is down 20.27 percent on the month, hurt by the lagging earnings for the second quarter. But with Thursday's offering, the stock shot up 11.17 percent to hit $4.47 a share.

(image courtesy of Wikimedia Commons)

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Symbol Name Price Change % Volume
OXBC Oxford Bank Corp 10.75 0.00 0.00 0
XOMA XOMA Corporation 5.49 0.18 3.39 200,695


Emerging Growth

Sack Lunch Productions Inc

Sack Lunch Productions Inc is an entertainment company. The Company, through its subsidiaries, is engaged in event management, production service, film production and distribution services.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…